Home / Compliance actions / 736152

FDA Warning Letter — Exxon / Spring Valley Station

Case 736152 — FEI 3047464720

The FDA took a Warning Letter action against Exxon / Spring Valley Station on Aug 11, 2026 (Washington, DC). The action was issued by CTP and concerns tobacco products.

Action details

Facility
Exxon / Spring Valley Station
Date
Aug 11, 2026
Fiscal Year
2026
Product Type
Tobacco
Center
CTP
Location
Washington, DC (United States)

Facility

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.